NAD+ Biosynthesis: Salvage Pathways, NMN, NR and Cellular Metabolism

Nicotinamide adenine dinucleotide, or NAD+, is continuously produced, consumed, and recycled within cells.

As discussed in our overview of NAD+ and cellular energy metabolism, NAD+ participates in redox reactions, mitochondrial metabolism, cellular signaling, and as a substrate for enzymes including sirtuins and PARPs.

But NAD+ is not simply stored indefinitely inside cells.

Cellular NAD+ pools are maintained through several interconnected biosynthetic pathways that use different molecular precursors.

Understanding these pathways provides a deeper view of how cells regulate NAD+ availability and why compounds such as nicotinamide, nicotinic acid, nicotinamide riboside (NR), and nicotinamide mononucleotide (NMN) appear frequently in NAD+ research.

The Three Major NAD+ Biosynthesis Pathways

Mammalian cells can produce NAD+ through three major routes:

• De novo biosynthesis
• The Preiss–Handler pathway
• NAD+ salvage pathways

These pathways begin with different precursors but eventually converge on common intermediates involved in NAD+ production.

A simplified model is:

Tryptophan → De novo pathway → NAD+

Nicotinic acid → Preiss–Handler pathway → NAD+

Nicotinamide / NR → Salvage pathways → NMN → NAD+

The actual biochemistry involves multiple enzymes and intermediate molecules.

What Is NAD+ Salvage?

Cells continually consume NAD+.

Certain NAD+-dependent enzymes cleave NAD+ during their reactions, frequently producing nicotinamide (NAM) as a product.

Rather than allowing all of that nicotinamide to be lost, cells can recycle it.

This process is called the NAD+ salvage pathway.

In simplified form:

NAD+ consumption → Nicotinamide → NMN → NAD+

This creates a biochemical recycling system that allows cells to regenerate NAD+ from material produced during previous NAD+-consuming reactions.

The nicotinamide salvage pathway represents a major source of NAD+ production in many mammalian cells.

NAMPT: A Critical Salvage Enzyme

One of the most important enzymes in this pathway is:

Nicotinamide phosphoribosyltransferase, or NAMPT.

NAMPT catalyzes the conversion of nicotinamide into nicotinamide mononucleotide (NMN).

The simplified reaction is:

Nicotinamide → NAMPT → NMN

This is commonly described as a rate-limiting step in the nicotinamide salvage pathway.

Because of its position in the pathway, NAMPT has become an important research target in studies of cellular metabolism and NAD+ homeostasis.

What Is NMN?

Nicotinamide mononucleotide (NMN) is a nucleotide intermediate in NAD+ biosynthesis.

NMN can be generated from nicotinamide through NAMPT.

It can also arise through metabolism of another NAD+ precursor, nicotinamide riboside.

NMN is then converted into NAD+ by enzymes known as nicotinamide mononucleotide adenylyltransferases, abbreviated NMNATs.

Thus:

NAM → NAMPT → NMN → NMNAT → NAD+

NMN is therefore not identical to NAD+.

It is a biosynthetic intermediate that cells can use in pathways leading to NAD+ production.

What Is Nicotinamide Riboside?

Nicotinamide riboside (NR) is another NAD+-related molecule.

NR can be phosphorylated by enzymes called nicotinamide riboside kinases, or NRKs.

This produces NMN.

The pathway can be simplified as:

NR → NRK → NMN → NMNAT → NAD+

NR and NMN therefore enter NAD+ biosynthesis at different points but converge before the final formation of NAD+.

NMNAT Enzymes

The conversion of NMN into NAD+ is catalyzed by NMNAT enzymes.

Mammals express multiple NMNAT isoforms.

These enzymes occupy different cellular environments, which is important because NAD+ metabolism is highly compartmentalized.

Rather than thinking of the cell as containing one uniform pool of NAD+, researchers increasingly examine NAD+ metabolism separately within structures such as the:

• Nucleus
• Cytosol
• Mitochondria

This spatial organization can influence how NAD+ participates in different cellular processes.

The Preiss–Handler Pathway

NAD+ can also be synthesized from nicotinic acid (NA), another form associated with vitamin B3 biology.

This occurs through the Preiss–Handler pathway.

The first major step involves the enzyme:

Nicotinic acid phosphoribosyltransferase (NAPRT)

which converts nicotinic acid into nicotinic acid mononucleotide (NAMN).

A simplified pathway is:

Nicotinic acid → NAPRT → NAMN → NAAD → NAD+

The later steps involve NMNAT enzymes and NAD synthetase.

NAMN Is Different From NMN

The terminology can become confusing.

NMN means:

Nicotinamide mononucleotide

while:

NAMN means:

Nicotinic acid mononucleotide.

These are different molecules.

NMN participates prominently in the amidated salvage pathway involving nicotinamide and NR.

NAMN participates in the pathway involving nicotinic acid and is also an intermediate generated during de novo NAD+ synthesis.

The similarity in their names makes distinguishing them important when interpreting NAD+ research.

De Novo NAD+ Biosynthesis

Cells can also produce NAD+ beginning with the amino acid tryptophan.

This is known as de novo NAD+ biosynthesis.

Tryptophan enters the kynurenine pathway and undergoes multiple enzymatic reactions.

One important intermediate generated along this pathway is quinolinic acid.

Quinolinic acid can then be converted by quinolinate phosphoribosyltransferase (QPRT) into NAMN.

From there, the pathway converges with later portions of the Preiss–Handler pathway.

A simplified representation is:

Tryptophan → Kynurenine pathway → Quinolinic acid → QPRT → NAMN → NAAD → NAD+

Why Have Multiple NAD+ Pathways?

Biological systems often maintain more than one route for producing essential metabolites.

Different NAD+ pathways allow cells to utilize different available precursors.

Their relative contribution can vary according to:

• Cell type
• Tissue
• Nutrient availability
• Enzyme expression
• Metabolic state
• Cellular stress
• Subcellular location

This means that the phrase “NAD+ production” actually describes a network rather than one biochemical reaction.

NAD+ Is Also Continuously Consumed

NAD+ biosynthesis represents only one side of NAD+ homeostasis.

Cells also continually consume NAD+.

Major NAD+-consuming enzyme families include:

• Sirtuins
• PARPs
• CD38/CD157
• Other NAD+-consuming enzymes

These reactions connect NAD+ availability with cellular signaling, protein modification, DNA-damage responses, calcium-related signaling, and other biological processes.

Therefore:

NAD+ level = synthesis + recycling − consumption

Conceptually, NAD+ homeostasis depends on the balance among all three.

Sirtuins and NAD+

Sirtuins are NAD+-dependent enzymes involved in protein deacylation and related reactions.

Mammals possess multiple sirtuins with different cellular locations and biological functions.

Because their enzymatic reactions require NAD+, sirtuins create a connection between cellular metabolic state and regulatory signaling.

Their reactions also generate nicotinamide.

That nicotinamide can subsequently become available for NAD+ salvage.

This produces an interesting biochemical cycle:

NAD+ → Sirtuin reaction → Nicotinamide → NAMPT → NMN → NAD+

The cell is therefore continually consuming and rebuilding NAD+-related molecules.

PARPs and NAD+ Consumption

Poly(ADP-ribose) polymerases, or PARPs, are another important class of NAD+-consuming enzymes.

Some PARPs become activated during cellular responses to DNA damage.

They use NAD+ to generate ADP-ribose modifications involved in cellular signaling and DNA-damage responses.

High levels of PARP activity can therefore influence NAD+ availability.

This illustrates why NAD+ biology cannot be understood solely by examining how much NAD+ a cell produces.

Consumption matters too.

CD38 and NAD+ Metabolism

CD38 is another major NAD+-consuming enzyme.

It has NAD glycohydrolase activity and participates in signaling processes involving NAD+-derived metabolites.

CD38 has become particularly interesting in NAD+ research because changes in its activity can influence cellular NAD+ pools.

Research has investigated CD38 in relation to metabolism, immune biology, cellular signaling, and age-associated changes in NAD+ homeostasis.

NAD+ Compartmentalization

One of the more important developments in modern NAD+ research is recognition that NAD+ is compartmentalized.

Cells contain distinct NAD+/NADH environments within different compartments.

Major pools include:

Cytosolic NAD+

Nuclear NAD+

Mitochondrial NAD+

These pools interact with different enzymes and metabolic pathways.

Consequently, an increase in total cellular NAD+ does not necessarily mean that NAD+ availability changed equally everywhere inside the cell.

Mitochondrial NAD+

Mitochondria rely heavily on NAD+/NADH chemistry.

NADH generated during metabolic reactions carries electrons that can enter the mitochondrial electron transport chain.

The oxidation of NADH back to NAD+ is therefore closely connected with mitochondrial energy metabolism.

At the same time, mitochondrial NAD+ participates in additional enzymatic processes.

This means mitochondrial NAD+ has both metabolic and signaling significance.

Cytosolic NAD+

The cytosolic NAD+/NADH system participates prominently in reactions such as glycolysis.

For glycolysis to continue, NADH generated during the pathway must ultimately be reoxidized so that NAD+ remains available.

Cells use metabolic pathways and shuttle systems to coordinate reducing equivalents between cellular compartments.

Thus, the amount of NAD+ present is only part of the story.

The NAD+/NADH ratio and redox state also matter.

Nuclear NAD+

Nuclear NAD+ is particularly relevant to NAD+-consuming regulatory enzymes.

PARPs and nuclear sirtuins can utilize NAD+ during processes involving:

• DNA-damage signaling
• Chromatin regulation
• Protein modification
• Gene regulation

This creates a direct connection between NAD+ metabolism and nuclear cellular regulation.

NAD+ Pools Are Dynamic

It is tempting to think of NAD+ as a static quantity that simply rises or falls.

The reality is more dynamic.

NAD+ molecules are constantly:

• Synthesized
• Reduced to NADH
• Reoxidized
• Consumed enzymatically
• Recycled
• Distributed among cellular compartments

Researchers therefore increasingly study NAD+ flux and homeostasis, rather than focusing only on a single concentration measurement.

NMN and NR Are Precursors, Not NAD+

NMN and NR are frequently discussed alongside NAD+, but the molecules should not be treated as interchangeable.

NR

→ NAD+ precursor

NMN

→ NAD+ biosynthetic intermediate/precursor

NAD+

→ Functional cellular coenzyme and signaling substrate

The biological consequences of administering or studying one molecule cannot automatically be assumed to be identical to studying another.

Their transport, metabolism, tissue distribution, and conversion must all be considered.

NAD+ Biosynthesis and Aging Research

NAD+ metabolism has become a major area of aging research.

Studies have reported age-associated alterations in NAD+ availability and in enzymes involved in NAD+ synthesis and consumption.

Researchers have consequently investigated whether modifying pathways involving NAMPT, NMN, NR, CD38, sirtuins, or related systems can alter aspects of age-associated biology.

However, this field requires careful interpretation.

Mechanistic findings and animal experiments involving NAD+ metabolism do not automatically demonstrate specific anti-aging effects in humans.

Why Increasing a Precursor Does Not Guarantee a Specific Outcome

Biological pathways contain multiple regulatory steps.

Providing more of an NAD+ precursor does not necessarily mean:

more precursor → unlimited NAD+ → predictable biological effect

Instead, the response can depend on:

• Transport
• Enzyme availability
• Tissue distribution
• Compartmentalization
• NAD+ consumption
• Feedback mechanisms
• Baseline metabolic state

This is why NAD+ precursor research must measure actual biological outcomes rather than relying solely on pathway diagrams.

Why NAD+ Biosynthesis Research Matters

NAD+ biosynthesis connects several fundamental areas of cellular biology:

• Energy metabolism
• Mitochondrial function
• Redox chemistry
• Nutrient metabolism
• DNA-damage signaling
• Sirtuin biology
• Cellular stress responses
• Metabolic regulation

Understanding how NAD+ is synthesized and recycled provides a foundation for interpreting research involving NAD+, NMN, NR, nicotinamide, and related metabolic pathways.

Interpreting NAD+ Precursor Research

When evaluating a study involving NAD+ metabolism, researchers should identify exactly what compound was investigated.

Important distinctions include:

NAD+ ≠ NMN ≠ NR ≠ Nicotinamide ≠ Nicotinic acid

Researchers should also distinguish among:

• Biochemical studies
• Cell-culture experiments
• Animal studies
• Human pharmacokinetic studies
• Controlled human trials

Evidence that a precursor raises NAD+ in a particular experimental model does not automatically establish a downstream physiological or clinical benefit.

Continue Exploring Metabolic Research

For the foundation behind this article, read NAD+ and Cellular Energy Metabolism: A Scientific Overview in the Chimera Research Labs Research Library.

You can also explore our Metabolic & Growth Research collection and the NAD+ research compound page for additional compound-specific information.

Research Use Only

Research compounds offered by Chimera Research Labs are intended for laboratory research purposes only.

They are not intended for human consumption or self-administration and are not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Research compounds should be handled only in accordance with applicable laws, regulations, institutional requirements, and appropriate laboratory practices.